The Column Group LLC
- SEC CIK
- 0001833486
- Latest filing
- Aug 14, 2026
Holdings in Q1 2024
Holdings as of Mar 31, 2024, filed May 15, 2024. Long positions only; changes compare share counts with Q4 2023.
- Positions
- 7
- +1 vs. Q4 2023
- Portfolio value
- $160.5M
- +$9.16M (+6.1%) vs. Q4 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| RVMDRevolution Medicines, Inc. | COM | 46 | $1.48K | <0.1% | 00.0% | Unchanged | History |
| SGMTSagimet Biosciences Inc. | COM SER A | 17,169 | $93.1K | 0.1% | +17,169 | New | History |
| SRZNSurrozen, Inc. | COM | 616,540 | $9.69M | 6.0% | −11,111−1.8% | Reduced | History |
| RAPTRAPT Therapeutics, Inc. | COM | 2,680,621 | $24.1M | 15.0% | 00.0% | Unchanged | History |
| NGMNGM Biopharmaceuticals Inc | COM | 18,136,735 | $28.8M | 18.0% | 00.0% | Unchanged | History |
| ORICOric Pharmaceuticals, Inc. | COM | 3,540,777 | $48.7M | 30.3% | −27,404−0.8% | Reduced | History |
| TNYATenaya Therapeutics, Inc. | COM | 9,400,290 | $49.2M | 30.6% | 00.0% | Unchanged | History |